SENTINEL NODE BIOPSY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Sentinel Node Biopsy Market, By Product Type (Surgical Instruments (Needles, Probes, Others), Imaging Agents (Radioactive Tracers, Fluorescent Dyes, Contrast Agents, and Diagnostic Kits), By Application (Breast Cancer, Melanoma, Colon Cancer, and Other Cancers), By Procedure Type (Open Surgery and Minimally Invasive Surgery) By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Research Laboratories, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In April 2024, Hologic, Inc., a medical technology company, entered a definitive agreement to acquire Endomagnetics Ltd., a U.K.-based company specializing in breast cancer surgery technologies. The acquisition, valued at approximately USD 310 million, enhances Hologic, Inc.’s capabilities in breast cancer surgery localization and lymphatic tracing with products like the Sentimag platform, Magseed marker, and Magtrace injectables.
In January 2024, Sahlgrenska University Hospital, one of Sweden's largest hospitals, completed a clinical trial on the use of ultra-low doses of superparamagnetic iron oxide nanoparticles for sentinel lymph node localization in breast cancer patients. The trial, conducted between January 2023 and January 2024, involved 220 participants and aimed at advancing lymphatic tracing methods in breast cancer surgery.